Chin 2017 US Patent

From Bioblast
Revision as of 16:06, 26 February 2018 by Kandolf Georg (talk | contribs) (Created page with "{{Publication |title=Chin MT, Chien WM, Dinca A (2017) Methods for treating and preventing cardiomyopathy. US Patent WO2016094791A1. |info=[https://patents.google.com/patent/W...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Publications in the MiPMap
Chin MT, Chien WM, Dinca A (2017) Methods for treating and preventing cardiomyopathy. US Patent WO2016094791A1.

» Open Access

Chin MT, Chien WM, Dinca A (2017) US Patent

Abstract: Methods for treating patients having a cardiomyopathy are provided. Additionally, methods for prophylactically treating patients at risk of developing a cardiomyopathy are provided. Methods for treating patients having, or at risk of developing, a cardiomyopathy may comprise administering a fusion protein including a tafazzin peptide and a cellular permeability peptide to the patient. Further, the tafazzin peptide may be coupled to the cellular permeability peptide by a polypeptide linker.


Bioblast editor: Kandolf G


Labels: MiParea: Respiration, mt-Structure;fission;fusion  Pathology: Inherited, Myopathy 

Organism: Mouse  Tissue;cell: Heart  Preparation: Homogenate 


Coupling state: LEAK, OXPHOS, ET  Pathway: N, CIV, ROX  HRR: Oxygraph-2k 

Labels, 2018-02